Literature DB >> 1191431

Complete heart block. Studies of atrial and ventricular pacemaker site and function.

D H Dighton.   

Abstract

Atrial and ventricular pacemaker function was studied in 20 patients with idiopathic chronic complete heart block using the rate response to an intravenous bolus dose of isoprenaline (5 mug/70 kg bodyweight). Pacemaker responses were compared with those of 16 normal control subjects. None of the patients was having syncopal attacks at the time of admission and they were therefore selected in that none required immediate pacing. Ten of the patients had His bundle electrograms; all were shown to have a pre-His type of atrioventricular block. Two major groups emerge from the responses to isoprenaline. (a) High risk group: 11 of the 14 patients with reduced ventricular pacemaker responses had frequent syncopal attacks; 8 of the patients with Adams-Stokes syncope had a bundle-branch block pattern, while 3 had a narrow QRS. These patients require pacing. (b) Low risk group: a low risk asymptomatic group (5 patients) was identified with atrial and ventricular responses to isoprenaline within normal range. One of these patients had a bundle-branch block pattern, while 4 had a narrow QRS. These patients might be managed without pacing. The atrial response to isoprenaline was reduced in 12 of the 20 cases, 10 of whom also had reduced ventricular responses. All 9 patients with bundle-branch block had reduced ventricular responses, while 7 had reduced atrial responses. This evidence indicates that cardiac conducting tissue pathophysiology is widespread in complete heart bolck. The present work suggests that consideration of the ventricular pacemaker function is important in assessing liability to syncope in complete heart block. While patients with Adams-Stokes attacks require pacing it is suggested that all asymptomatic patients with complete heart block and those with minor symptoms are assessed using studies of both ventricular pacemaker function and site. A low risk group not requiring a pacemaker may emerge after sufficient follow-up assessment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191431      PMCID: PMC482933          DOI: 10.1136/hrt.37.11.1156

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

1.  Cornelio Papp 1903-1974.

Authors:  K S Smith
Journal:  Br Heart J       Date:  1975-03

2.  THE ELECTROCARDIOGRAM OF THE STOKES-ADAMS ATTACK.

Authors:  J Parkinson; C Papp; W Evans
Journal:  Br Heart J       Date:  1941-07

3.  Congenital heart block with fatal Adams-Stokes attacks in childhood.

Authors:  M E MOLTHAN; R A MILLER; A R HASTREITER; M H PAUL
Journal:  Pediatrics       Date:  1962-07       Impact factor: 7.124

4.  Role of autonomic nervous system in chronic complete heart block.

Authors:  J F Finucane; J Gialafos
Journal:  Br Heart J       Date:  1974-10

5.  Sinus bradycardia. Autonomic influences and clinical assessment.

Authors:  D H Dighton
Journal:  Br Heart J       Date:  1974-08

6.  Assessment of sinus node function in patients with the sick sinus syndrome.

Authors:  W J Mandel; H Hayakawa; H N Allen; R Danzig; A I Kermaier
Journal:  Circulation       Date:  1972-10       Impact factor: 29.690

7.  Site of heart block as defined by His bundle recording. Pathologic correlations in three cases.

Authors:  K M Rosen; S H Rahimtoola; R M Gunnar; M Lev
Journal:  Circulation       Date:  1972-05       Impact factor: 29.690

8.  Sites of congenital and surgical heart block as defined by His bundle electrocardiography.

Authors:  K M Rosen; A Mehta; S H Rahimtoola; R A Miller
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

Review 9.  Congenital complete heart block in children.

Authors:  C R Ayers; J P Boineau; M S Spach
Journal:  Am Heart J       Date:  1966-09       Impact factor: 4.749

  9 in total
  1 in total

1.  Heart block in children. Evaluation of subsidiary ventricular pacemaker recovery times and ECG tape recordings.

Authors:  D W Benson; M S Spach; S B Edwards; R Sterba; G A Serwer; B E Armstrong; P A Anderson
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.